Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent Prostate Carcinoma”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Large-scale testing (Phase 3)Ended earlyNCT05744115
What this trial is testing

Ga-68-PSMA-11 in Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Timothy Hoffman 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Large-scale testing (Phase 3)Study completedNCT01272050
What this trial is testing

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 350
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Early research (Phase 1)Active Not RecruitingNCT06105918
What this trial is testing

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
Emory University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07365423
What this trial is testing

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Who this might be right for
Recurrent Prostate Cancer
Swiss Cancer Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT04978675
What this trial is testing

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02020070
What this trial is testing

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT04050215
What this trial is testing

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+6 more
Jonsson Comprehensive Cancer Center 937
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543
What this trial is testing

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04206319
What this trial is testing

Radium-223 in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00908141
What this trial is testing

GM-CSF in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Early research (Phase 1)Active Not RecruitingNCT05077098
What this trial is testing

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
Mark Stein 8
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Load More Results